Deferred Tax Assets, Valuation Allowance in USD of Cabaletta Bio, Inc. from Q4 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cabaletta Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2018 to Q4 2024.
  • Cabaletta Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $111M, a 52.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Cabaletta Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $111M +$38.2M +52.6% 31 Dec 2024 10-K 31 Mar 2025
Q4 2023 $72.6M +$22.9M +46% 31 Dec 2023 10-K 31 Mar 2025
Q4 2022 $49.7M +$13.5M +37.2% 31 Dec 2022 10-K 21 Mar 2024
Q4 2021 $36.2M +$17.2M +90.9% 31 Dec 2021 10-K 16 Mar 2023
Q4 2020 $19M +$11.8M +163% 31 Dec 2020 10-K 17 Mar 2022
Q4 2019 $7.22M +$5.61M +348% 31 Dec 2019 10-K 16 Mar 2021
Q4 2018 $1.61M 31 Dec 2018 10-K 30 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.